140 related articles for article (PubMed ID: 29340079)
1. High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma.
Tu J; Ying X; Zhang D; Weng Q; Mao W; Chen L; Wu X; Tu C; Ji J; Huang Y
Oncotarget; 2017 Dec; 8(67):111623-111630. PubMed ID: 29340079
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis.
Wang W; Zhu G; Lai S; Guo Y; Yin X; Chen D; Wen L
Med Sci Monit; 2020 Feb; 26():e919896. PubMed ID: 32090983
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer.
Wang Y; Shi F; Tao R; Wu J; Gu J; Yang R; Wu S
Cancer Manag Res; 2021; 13():5919-5930. PubMed ID: 34354374
[TBL] [Abstract][Full Text] [Related]
5. Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.
Liu S; Wei Y; Nie L; Tang Z; Lu Q; Liang Q
BMC Cancer; 2024 May; 24(1):614. PubMed ID: 38773427
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
8. High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer.
Yao HH; Wang BJ; Wu Y; Huang Q
Med Sci Monit; 2017 Mar; 23():1286-1294. PubMed ID: 28289272
[TBL] [Abstract][Full Text] [Related]
9. Expression of AGGF1 and Twist1 in hepatocellular carcinoma and their correlation with vasculogenic mimicry.
Mao X; Wu X; Guo J; Deng M; Zhang H; Ma T; Yu L
Int J Clin Exp Pathol; 2020; 13(7):1646-1654. PubMed ID: 32782684
[TBL] [Abstract][Full Text] [Related]
10. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway.
Li W; Fu Q; Man W; Guo H; Yang P
Eur J Pharmacol; 2019 Apr; 849():106-114. PubMed ID: 30710550
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions.
Zhan M; Hori Y; Wada N; Ikeda J; Hata Y; Osuga K; Morii E
Acta Histochem Cytochem; 2016 Apr; 49(2):75-81. PubMed ID: 27222614
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
Zhu JY; Sun QK; Wang W; Jia WD
Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer.
Zhang X; Sun H; Chen W; He X
BMC Cancer; 2019 Dec; 19(1):1252. PubMed ID: 31881864
[TBL] [Abstract][Full Text] [Related]
14. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery.
Wang Q; Tian X; Zhang C; Wang Q
Med Oncol; 2012 Dec; 29(4):2727-36. PubMed ID: 22101788
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work.
Murakami K; Kasajima A; Kawagishi N; Ohuchi N; Sasano H
Hepatol Res; 2015 Dec; 45(12):1185-94. PubMed ID: 25594920
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
[TBL] [Abstract][Full Text] [Related]
19. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
Sun HC; Tang ZY; Li XM; Zhou YN; Sun BR; Ma ZC
J Cancer Res Clin Oncol; 1999 Jul; 125(7):419-26. PubMed ID: 10394963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
